Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

CLPT
ClearPoint Neuro, Inc. Common Stock
stock NASDAQ

At Close
Aug 3, 2026 3:59:55 PM EDT
15.36USD+2.811%(+0.42)680,965
12.69Bid   13.37Ask   0.68Spread
Pre-market
Aug 3, 2026 9:28:30 AM EDT
14.90USD-0.268%(-0.04)4,896
After-hours
Aug 3, 2026 4:59:30 PM EDT
12.81USD-16.631%(-2.55)144,757
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 5, 2022
04:05PM EST  ClearPoint Neuro to Participate at the H.C. Wainwright BIOCONNECT   GlobeNewswire Inc
Nov 17, 2021
04:05PM EST  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates partner Blackrock Neurotech for receiving Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its groundbreaking MoveAgain Brain Computer Interface (BCI) system.   GlobeNewswire Inc
Nov 9, 2021
04:49PM EST  ClearPoint Neuro Sees Q3 Sales $16M-$17.5M vs $16.1M Est.   Benzinga
04:46PM EST  ClearPoint Neuro Q3 EPS $(0.18) Misses $(0.16) Estimate, Sales $4.60M Beat $4.00M Estimate   Benzinga
11:25AM EST  Earnings Scheduled For November 9, 2021   Benzinga
11:09AM EST  ClearPoint Neuro Congratulates Neurona Therapeutics On IND Clearance For Neural Cell Therapy NRTX-1001 In Chronic Focal Epilepsy Patients   Benzinga
Nov 8, 2021
04:05PM EST  ClearPoint Neuro Congratulates Neurona Therapeutics on IND   GlobeNewswire Inc
Nov 2, 2021
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Linda M. Liau, MD, PhD, MBA, has been appointed to the Companys Board of Directors effective immediately.   GlobeNewswire Inc
Oct 26, 2021
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2021 third quarter on Tuesday, November 9, 2021, after the market close.   GlobeNewswire Inc
Sep 22, 2021
12:30PM EDT  ClearPoint Neuro's Return On Capital Employed Overview   Benzinga
Aug 11, 2021
02:15PM EDT  ClearPoint Neuro Stock Dives After Q2 Earnings   Benzinga
Aug 10, 2021
04:48PM EDT  Recap: ClearPoint Neuro Q2 Earnings   Benzinga
04:44PM EDT  ClearPoint Neuro Sees FY21 Sales $16M-$17.5M vs $16.4M Estimate   Benzinga
04:40PM EDT  ClearPoint Neuro Q2 EPS $(0.17) Misses $(0.13) Estimate, Sales $3.41M Miss $3.68M Estimate   Benzinga
07:55AM EDT  The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts   Benzinga
04:05AM EDT  Earnings Scheduled For August 10, 2021   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
08:08AM EDT  ClearPoint Neuro, Inc. Announces Partnership With adeor medical AG; Co. To Act As Distributor In US For adeor's Surgical Drill System   Benzinga
08:00AM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced it has entered into a strategic and commercial partnership with German-based surgical equipment leader adeor medical AG for powered neurosurgical drill solutions.   GlobeNewswire Inc
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 4, 2021
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its ClearPoint Neuro Navigation System at Hpital Fondation Rothschild in Paris, France.   GlobeNewswire Inc
Aug 2, 2021
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2021 second quarter on Tuesday, August 10, 2021, after the market close.   GlobeNewswire Inc
Jul 21, 2021
04:05PM EDT  Blackrock Neurotech, ClearPoint Neuro to Address Neurological   GlobeNewswire Inc
Jul 15, 2021
04:30PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Companys Board of Directors effective immediately. Ms. Fallon will also become a member of the Companys Audit Committee.   GlobeNewswire Inc
Jun 18, 2021
10:18AM EDT  ClearPoint Neuro: Return On Capital Employed Insights   Benzinga
Jun 16, 2021
04:16PM EDT  ClearPoint Neuro Highlights Installation Of ClearPoint 2.0 Software At Mazowiecki Szpital Brodnowski In Poland   Benzinga
04:16PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced the installation of its version 2.0 software at Mazowiecki Szpital Brdnowski in Warsaw, Poland.   GlobeNewswire Inc
Jun 14, 2021
09:16AM EDT  ClearPoint Neuro Set To Join Russell 3000 Index June 28   Benzinga
09:15AM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, is set to join the broad-market Russell 3000 Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28, according to a preliminary list of additions posted June 4.   GlobeNewswire Inc
Jun 8, 2021
07:30AM EDT  ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on   GlobeNewswire Inc
Jun 3, 2021
11:06AM EDT  ClearPoint Neuro Insights: Return On Capital Employed   Benzinga
May 19, 2021
04:07PM EDT  ClearPoint Neuro To Present At UBS Global Healthcare Virtual Conference May 26   Benzinga
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, announced today that its management will present at the UBS Global Healthcare Virtual Conference on Wednesday, May 26, 2021 at 12:00 p.m. Eastern Time.   GlobeNewswire Inc
May 18, 2021
04:07PM EDT  ClearPoint Neuro, Inc. Announces First-in-Human Cases Of The SmartFrame Array Neuro Navigation System and Software   Benzinga
04:05PM EDT  ClearPoint Neuro, Inc. Announces First-in-Human Cases of the   GlobeNewswire Inc
May 12, 2021
12:47PM EDT  MedTech Round Up: Update On Lucira Health, Second Sight Medical ClearPoint Neuro, Medtronic, Sientra   Benzinga
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
May 11, 2021
04:40PM EDT  ClearPoint Neuro: Q1 Earnings Insights   Benzinga
04:40PM EDT  ClearPoint Neuro Announces FDA Clearance Of SmartFrame Array   Benzinga
04:40PM EDT  ClearPoint Neuro Sees FY22 Sales $16M-$17.5M vs $15.83M Est   Benzinga
04:37PM EDT  ClearPoint Neuro Q1 EPS $(0.13) Beats $(0.14) Estimate, Sales $4.03M Beat $3.27M Estimate   Benzinga
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced financial results for its first quarter ended March 31, 2021.   GlobeNewswire Inc
12:47PM EDT  Earnings Scheduled For May 11, 2021   Benzinga
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
04:14AM EDT  Earnings Scheduled For May 11, 2021   Benzinga
May 10, 2021
05:21PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a partnership with San Diego-based D&K Engineering for the continued development of a robotic system for use in both the MRI Suite and the Operating Room.   GlobeNewswire Inc
Apr 28, 2021
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today congratulates Voyager Therapeutics on receiving FDA clearance of the IND application for their gene therapy candidate VY-HTT01 for the treatment of Huntingtons disease.   GlobeNewswire Inc
Apr 23, 2021
05:00PM EDT  ClearPoint Neuro Reports Inducement Grants Under NASDAQ Listing   GlobeNewswire Inc
Apr 13, 2021
04:05PM EDT  ClearPoint Neuro, Inc. Announces Retirement of Director John N.   GlobeNewswire Inc
Apr 6, 2021
05:30PM EDT  How Jonah Lupton Expects TransMedics Group Stock To React To FDA Decision   Benzinga
04:05PM EDT  ClearPoint Neuro, Inc. Congratulates uniQure on Completion of   GlobeNewswire Inc
Mar 24, 2021
04:05PM EDT  ClearPoint Neuro, Inc. Announces Appointment of Ellisa Cholapranee   GlobeNewswire Inc
Mar 18, 2021
10:02AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For March 18, 2021   Benzinga
09:11AM EDT  Lake Street Initiates Coverage On ClearPoint Neuro with Buy Rating, Announces Price Target of $32   Benzinga
Mar 5, 2021
10:55AM EST  ClearPoint Neuro shares were trading higher after the company reported better-than-expected Q4 EPS results.   Benzinga
Mar 4, 2021
04:33PM EST  Recap: ClearPoint Neuro Q4 Earnings   Benzinga
04:20PM EST  ClearPoint Neuro Q4 EPS $(0.09) Beats $(0.13) Estimate, Sales $3.70M Inline   Benzinga
04:05PM EST  ClearPoint Neuro Reports Fourth Quarter and Full-Year 2020 Results   GlobeNewswire Inc
08:12AM EST  The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company   Benzinga
04:07AM EST  Earnings Scheduled For March 4, 2021   Benzinga
Feb 27, 2021
09:04PM EST  The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings   Benzinga
Feb 23, 2021
04:05PM EST  ClearPoint Neuro Announces Closing of Public Offering of 2,127,660   GlobeNewswire Inc
Feb 19, 2021
04:05PM EST  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it will release financial results for its 2020 fourth quarter and full year, which ended December 31, 2020, on Thursday, March 4, 2021, after the market close.   GlobeNewswire Inc
07:25AM EST  The Daily Biotech Pulse: Novavax Vaccine Supply Deal, Orphan Drug Designation For Travere, COVID-19 Boost For Quidel, Opko   Benzinga
05:56AM EST  ClearPoint Neuro Secures $43M Via Equity At 9% Discount   Benzinga
05:39AM EST  ClearPoint Neuro Priced Public Offering of 1,850,140 Shares of Common Stock @$23.50/Share   Benzinga
Feb 18, 2021
04:42PM EST  ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips; Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint 'Maestro' Brain Model by 2022   Benzinga
04:37PM EST  ClearPoint Neuro Reports Offering Of Common Stock, No Size Disclosed   Benzinga
04:15PM EST  ClearPoint Neuro, Inc. Announces License and Research Agreement with Philips; Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint 'Maestro' Brain Model by 2022   Benzinga
04:05PM EST  Collaboration will Enable ClearPoint to Develop and Launch the ClearPoint Maestro Brain Model by 2022   GlobeNewswire Inc
Feb 17, 2021
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
Feb 11, 2021
04:13PM EST  ClearPoint Neuro, Inc. Announces Multi-Product Joint Development & Option Agreement with Blackrock Microsystems   Benzinga
04:05PM EST  ClearPoint Neuro, Inc. Announces Multi-Product Joint Development &   GlobeNewswire Inc
Feb 10, 2021
07:34AM EST  The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs   Benzinga
Feb 5, 2021
08:21AM EST  ClearPoint Neuro Appoints John Fletcher As Chairman   RTTNews
08:00AM EST  ClearPoint Neuro, Inc. Announces Appointment of R. John Fletcher   GlobeNewswire Inc
Jan 27, 2021
07:36AM EST  The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement   Benzinga
Jan 26, 2021
04:05PM EST  ClearPoint Neuro, Inc. Announces Expansion of Pre-Clinical and   GlobeNewswire Inc
08:07AM EST  The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market   Benzinga
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 14, 2021
04:06PM EST  ClearPoint Neuro Announces First Procedure Utilizing ClearPoint 2.0 Software In Europe   Benzinga
04:05PM EST  ClearPoint Neuro, Inc. Announces First Procedure Utilizing   GlobeNewswire Inc
Jan 13, 2021
07:25AM EST  The Daily Biotech Pulse: Bausch Health Issues Positive Pre-Announcement, Acorda Streamlines Operations   Benzinga
Jan 12, 2021
04:08PM EST  ClearPoint Neuro Sees Q4 Prelim. Sales $3.7M Vs. $3.29M Est., FY20 Prelim. Sales 12.8M Vs. $12.4M Est.   Benzinga
04:05PM EST  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company), a global therapy-enabling platform company providing navigation and delivery to the brain, today reported preliminary unaudited revenue results for the quarter and full year ended December 31, 2020.   GlobeNewswire Inc
Jan 5, 2021
08:39AM EST  The Daily Biotech Pulse: Moderna Coronavirus Vaccine Receives Third Regulatory Nod, Gritstone Rallies On Hedge Fund Stake, aTyr's COVID-19 Drug Data   Benzinga
Dec 30, 2020
08:16AM EST  The Daily Biotech Pulse: Osmotica Faces Second FDA Rejection, UK Conditionally Approves AstraZeneca's Vaccine Candidate, Hepion NASH Data   Benzinga
Dec 29, 2020
04:16PM EST  ClearPoint Neuro Reports $7.5M In Added Funding Of Existing Convertible Notes   Benzinga
04:15PM EST  ClearPoint Neuro, Inc. Announces Funding of Additional $7.5M of   GlobeNewswire Inc
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 18, 2020
07:48AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Vote, Mesoblast Sinks On Data   Benzinga
07:45AM EST  The Daily Biotech Pulse: FDA Nod For Amgen's Biosimilar, Moderna's Vaccine Approved, Mesoblast Sinks On Data   Benzinga
Nov 30, 2020
09:15AM EST  ClearPoint Neuro, Inc. (Nasdaq: CLPT), a leader in image-guided stereotactic neurosurgery, announced that its 4,000th neurosurgical procedure using the ClearPoint Neuro Navigation System was completed earlier this month at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.   GlobeNewswire Inc
Nov 24, 2020
08:13AM EST  The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 16, 2020
10:02AM EST  68 Stocks Trading Near 52-Week Highs Just After Open On Monday, Nov. 16, 2020:   Benzinga
Nov 11, 2020
07:38AM EST  The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap   Benzinga
Nov 10, 2020
05:05PM EST  Recap: ClearPoint Neuro Q3 Earnings   Benzinga
04:52PM EST  ClearPoint Neuro Q3 EPS $(0.09) Beats $(0.14) Estimate, Sales $3.50M Beat $2.47M Estimate   Benzinga
04:05PM EST  ClearPoint Neuro, Inc. (Nasdaq: CLPT), a medical device company with a portfolio of products focused on enabling therapies for neurological disorders, today announced financial results for its third fiscal quarter ended September 30, 2020.   GlobeNewswire Inc
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Nov 4, 2020
04:05PM EST  ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the Company) today announced that it will release financial results for its 2020 third quarter, which ended September 30, 2020, on Tuesday, November 10, 2020 after the market close. The Company will subsequently conduct a conference call and webcast that day to review its results at 4:30 p.m. Eastern (1:30 p.m. Pacific).   GlobeNewswire Inc
Sep 14, 2020
04:16PM EDT  ClearPoint Neuro Announces That Danilo D'Alessandro Has Been Appointed As CFO   Benzinga
04:15PM EDT  ClearPoint Neuro Announces Transition Plan for New Chief Financial   GlobeNewswire Inc
Aug 12, 2020
04:14PM EDT  ClearPoint Neuro Q2 EPS $(0.11) Beats $(0.16) Estimate, Sales $1.59M Miss $1.88M Estimate   Benzinga
04:05PM EDT  ClearPoint Neuro, Inc. (Nasdaq: CLPT) today announced financial results for its second fiscal quarter and six months ended June 30, 2020.   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 12, 2020   Benzinga
Jul 20, 2020
05:11AM EDT  80 Biggest Movers From Friday   Benzinga
Jul 17, 2020
06:25AM EDT  B. Riley FBR Initiates Coverage On ClearPoint Neuro with Buy Rating, Announces Price Target of $8   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC